FDA Performance Tracker: Regularly updated information about new submissions, pending applications and FDA actions, brought to you by Pink Sheet.
Please contact Bridget Silverman (firstname.lastname@example.org) or Mary Jo Laffler (email@example.com) if you’d like assistance in utilizing these new tools, have questions, or have updated information on chart entries.
Latest From US FDA Performance Tracker
The latest drug development news and highlights from our US FDA Performance Tracker.
Highlights of year-end application submissions including candidates from AstraZeneca, BioMarin, Lilly, MorphoSys, and Seattle Genetics.
The latest news on novel drug approvals and complete response letters from our US FDA Performance Tracker.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.